Nearly 10 million people died from cancer in 2020. The disease incidence is increasing for several reasons: an aging population – most of the people diagnosed with cancer are older than 60; dietary changes; tobacco and alcohol use; and lack of physical activity. Cancer-causing infections, such as human papillomavirus (HPV) and hepatitis are also important drivers of increased cancer incidence.
Globally, prostate cancer is is the second most common cancer. Among African men, it is ranked 1^st in both incidence and mortality. Growing knowledge of human genetics is changing the way physicians and researchers approach both the diagnosis and the treatment of cancer. Genomic information about prostate cancer is leading to better diagnoses and treatment strategies.

Cervical cancer is a preventable disease. The main cause of cervical cancer is persistent infection with human papillomavirus (HPV), which is transmitted through sexual contact. Vaccines exist that protect against high-risk HPV types, and screening programmes can detect signs of disease. However, high incidence rates and high mortality rates for cervical cancer occur mainly in low- and middle-income countries.
Several key technologies have emerged in biomedical research. These types of analyses are now critical for performing effective research aimed at developing a better understanding of disease pathology, as well as for designing new approaches for clinical treatment. This conference will focus on the basic and molecular aspects of prostate and cervical cancer diseases. The aim is to give an overview of the current scenario of these  diseases, how their research fields are progressing, how to obtain valuable information from them, and how to teach this information to others. We have a line-up of outstanding speakers and leading experts, and the conference is an excellent opportunity for you to meet with exceptional investigators from all over the world, creating an unparalleled opportunity for networking and collaboration.